Arlington Capital Partners to Sell J&J Worldwide Services to CBRE
Achieving significant organic growth during its four-year partnership with Arlington, J&J is well-positioned under CBRE’s stewardship to continue its growth... Read more.
Stratasys Sets the Stage at Additive Manufacturing Strategies 2024
Company CEO Yoav Zeif to open the industry’s touchstone conference with keynote address on the state of additive manufacturing EDEN PRAIRIE, Minn. & REHOVOT,... Read more.
CBRE Group, Inc. Expands Public Sector Capabilities with Agreement to Acquire J&J Worldwide Services
DALLAS–(BUSINESS WIRE)–CBRE Group, Inc. (NYSE:CBRE) today announced a definitive agreement to acquire J&J Worldwide Services, a leading provider... Read more.
Intellicheck CEO Bryan Lewis to Present Updates at the Emerging Growth Conference 67 on February 8, 2024
MELVILLE, N.Y.–(BUSINESS WIRE)–$IDN #authentication—Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company delivering on-demand... Read more.
Digital Signature Market Analysis 2023-2033, Featuring Adobe, Thales Group, DocuSign & OneSpan – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Digital Signature Market: A Global and Regional Analysis, 2023-2033” report has been added to ResearchAndMarkets.com’s... Read more.
Medallia Commits to Net Zero by 2040
PLEASANTON, Calif.–(BUSINESS WIRE)–Medallia, Inc., the global leader in customer and employee experience, today announced a commitment to achieve net-zero... Read more.
Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion
SARASOTA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal nanoparticle pharmaceuticals... Read more.
Slam Corp. and Lynk Global, Inc. Announce Definitive Business Combination Agreement
Lynk’s proven two-way sat2phone connectivity is compatible with unmodified 2G to 5G mobile devices Lynk’s “cell-tower-in-space” satellites have been proven... Read more.
Ultima Genomics to Launch UG 100™ System and Present Data at AGBT
Robust scientific program around launch of UG 100™ featuring Early Access customers and collaborators Highlights new data and the unique benefits of the UG 100™... Read more.
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
LONDON–(BUSINESS WIRE)–$SLN #SenseofSilence–Silence Therapeutics plc (Nasdaq: SLN) (“Silence” or the “Company”), an experienced and innovative... Read more.